Recurrent Childhood Spinal Cord Neoplasm: Clinical Trials

3 trials for Recurrent Childhood Spinal Cord Neoplasm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Terminated 1

Follow Recurrent Childhood Spinal Cord Neoplasm: new trials by email Literature Review of Recurrent Childhood Spinal Cord Neoplasm trials Research Report on Recurrent Childhood Spinal Cord Neoplasm

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia
gamma-secretase/Notch signalling pathway inhibitor RO4929097, diagnostic laboratory biomarker analysis, pharmacological study - Childhood Atypical Teratoid/Rhabdoid Tumor, Childhood Central Nervous System Choriocarcinoma
Phase 1TerminatedNational Cancer Institute (NCI)1292010-03-012014-11-05
Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors
vorinostat, temozolomide, diagnostic laboratory biomarker analysis - Childhood Atypical Teratoid/Rhabdoid Tumor, Childhood Central Nervous System Choriocarcinoma
Phase 1CompletedNational Cancer Institute (NCI)272010-02-012013-05-03
ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors
veliparib, temozolomide, pharmacological study - Childhood Atypical Teratoid/Rhabdoid Tumor, Childhood Central Nervous System Germ Cell Tumor
Phase 1CompletedNational Cancer Institute (NCI)312009-07-012014-07-09

Narrower conditions

Astrocytoma (3)  ·  Choroid Plexus Neoplasms (3)  ·  Familial ependymoma (3)  ·  Medulloblastoma (3)  ·  Oligodendroglioma (3)  ·  Optic Nerve Glioma (3)  ·  Rhabdoid Tumor (3)  ·  Spinal Cord Neoplasms (3)  ·  Adenoma, Acidophil (1)  ·  Adenoma, Basophil (1)  ·  Adenoma, Chromophobe (1)  ·  Burkitt Lymphoma (1)  ·  Dendritic Cell Sarcoma, Interdigitating (1)  ·  Leukemia, Large Granular Lymphocytic (1)  ·  Lymphoma, Large-Cell, Anaplastic (1)

Broader conditions

Brain Diseases (3)  ·  Brain Neoplasms (3)  ·  Central Nervous System Diseases (3)  ·  Central Nervous System Neoplasms (3)  ·  Cerebral Ventricle Neoplasms (3)  ·  Cranial Nerve Diseases (3)  ·  Cranial Nerve Neoplasms (3)  ·  Eye Diseases (3)  ·  Glioma (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms by Site (3)  ·  Neoplasms, Complex and Mixed (3)  ·  Neoplasms, Germ Cell and Embryonal (3)  ·  Neoplasms, Glandular and Epithelial (3)

Interventions

Temozolomide (2)  ·  2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide (1)  ·  Calcium Dobesilate (1)  ·  Dexamethasone (1)  ·  Vorinostat (1)  ·  veliparib (1)

Sponsors

National Cancer Institute (NCI) (3)

Countries

United States (3)  ·  Canada (2)

Top investigators

Jack Su (1)  ·  Najat Daw (1)  ·  Trent Hummel (1)

Results publications

PMID 23554030

NIH funding

U01CA097452 (2), U01CA081457 (1)